SBI Large Cap Fund
The scheme seeks to provide investors with opportunities for long-term growth in capital through an active management of investments in a diversified basket of large cap equity stocks (as specified by SEBI/AMFI from time to time).
Growthvine rating: 3/5 — ranked #15 of 42 in category.
Fund basics
| Category | Equity: Large Cap |
|---|
| NAV | ₹86.84 (as of 2026-10-23) |
|---|
| AUM | ₹52,373 Cr |
|---|
| Expense ratio | 1.23% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Saurabh Pant |
|---|
| Exit load | 0.25% for redemption within 30 days. 0.1% for redemption after 30 days and within 90 days |
|---|
Performance & risk
| 5-year annualised return | 7.62% |
|---|
| Sharpe ratio | 0.19 |
|---|
| Standard deviation | 14.00% |
|---|
| Max drawdown | −61.45% |
|---|
| Alpha | -0.22 |
|---|
| Beta | 0.92 |
|---|
Over 5 years, captured 91.7% of NIFTY 100's upside and 85.1% of its downside.
Market cap allocation
| Large cap | 84.3% |
|---|
| Mid cap | 13.8% |
|---|
| Small cap | 1.9% |
|---|
Concentration
| Top 5 holdings | 30.2% |
|---|
| Top 10 holdings | 47.6% |
|---|
| Total holdings | 53 |
|---|
| Index overlap | 51.8% |
|---|
| Active share | 48.2% |
|---|
Top holdings
- ICICI Bank Ltd. — 8.3%
- HDFC Bank Ltd. — 8.2%
- Larsen & Toubro Limited — 5.3%
- Kotak Mahindra Bank Ltd. — 4.6%
- Samvardhana Motherson International Limited — 3.8%
- Divis Laboratories Ltd. — 3.6%
- Reliance Industries Ltd — 3.5%
- State Bank Of India — 3.5%
- Asian Paints Ltd. — 3.4%
- Infosys Ltd — 3.4%
Top sectors
- Banking & Financial — 29.0%
- Construction — 8.1%
- Pharma & Biotech — 7.7%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −9.8% | Q2 | #14 of 39 |
| 2025 | 9.7% | Q1 (Top) | #5 of 36 |
| 2024 | 12.5% | Q4 (Bottom) | #26 of 32 |
| 2023 | 22.6% | Q3 | #19 of 32 |
| 2022 | 4.4% | Q1 (Top) | #7 of 28 |